GOUVERNEUR E. J. Noble Hospital has received approval from the state Health Department to expand the menu of laboratory analyses that can be performed on site by hospital employees. The approval means caregivers and patients will be able to receive test results more quickly, speeding up diagnosis and treatment, especially for those receiving emergency care, according to a press release.
This is a major step forward for E. J. Noble Hospital and our community, Marlinda L. LaValley, E.J. Noble Hospitals CEO said in a statement. This approval was granted following a rigorous analysis by the states laboratory experts and reflects the very hard work our staff members have done to establish quality protocols that meet the states stringent requirements.
Tests available at E.J. Noble Hospital include analysis of blood and urine samples to aid in the diagnosis of congestive heart failure, tests for the diagnosis and management of pancreatitis or other pancreatic diseases, drug and alcohol screenings, tests to determine abnormalities in pregnancy, screenings for heart and lung functioning as well as deep vein thrombosis and infections of the blood, andother tests.
E. J. Noble will file regular reports with the Department of Health documenting its compliance with the states quality standards. Dr. Gregory Threatte, chairman of the pathology department at Upstate Medical University, will oversee the program as the labs medical director.
With the states approval, E. J. Noble has sent a required 30-day notice that will end its contract with Samaritan Medical Center, Watertown, for operation of the laboratory.